HomeCERO • NASDAQ
add
CERo Therapeutics Holdings Inc
Previous close
$0.25
Day range
$0.21 - $0.25
Year range
$0.064 - $12.38
Market cap
31.91M USD
Avg Volume
120.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.40M | 924.25% |
Net income | -4.23M | -1,165.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.29M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.38M | 2,740.17% |
Total assets | 6.49M | -23.36% |
Total liabilities | 10.19M | -54.16% |
Total equity | -3.70M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -158.78% | — |
Return on capital | 986.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.23M | -1,165.75% |
Cash from operations | -2.76M | -977.06% |
Cash from investing | — | — |
Cash from financing | 2.49M | 145.98% |
Net change in cash | -266.82K | -2,036.30% |
Free cash flow | -1.50M | -127.09% |
About
Founded
2020
Headquarters
Website
Employees
8
